JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
CIBRN Poll #2: With the expanding number of options available for treating specific conditions, is there merit in limiting choice by using a stratified or step approach to selection?
Sign in to Google
to save your progress.
Learn more
* Indicates required question
Email
*
Your email
With the expanding number of options available for treating specific conditions, is there merit in limiting choice by using a stratified or step approach to selection?
*
Yes, stratification should be used with the more costly biologic therapies.
Yes, stratification should be used for all classical and biologic therapies.
No, physicians and patients should be free to select any biologic therapy after failing traditional classical therapies.
No, physicians and patients should be free to select any classical or biologic therapy in any order once systemic therapy is indicated.
Submit
Clear form
This form was created inside of Sosido.com.
Report Abuse
Forms
